Verition Fund Management LLC Invitae Corp Put Options Transaction History

Verition Fund Management LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	SELL	$2.13 - $9.01 $412,368 - $1.74 Million	-193,600 Reduced 95.09%	10,000 $24,000
Q1 2022 May 13, 2022	BUY	$6.28 - $15.59 $1.28 Million - $3.17 Million	203,600 New	203,600 $1.62 Million
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $1.86 Million - $2.88 Million	-71,400 Closed	0 $0
Q1 2021 May 18, 2021	SELL	$33.06 - $56.93 $5.74 Million - $9.88 Million	-173,600 Reduced 70.86%	71,400 $2.73 Million
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $9.58 Million - $14.1 Million	245,000 New	245,000 $10.2 Million

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.